BioNTech SE · NASDAQ:BNTX

BioNTech — Investor Presentation (December 2023)

4 slides from BioNTech's investor presentation, December 2023

1. Slide 1: BioNTech

   BioNTech What it does Short 10 questions BioNTech, founded in 2008, is a biotech company using next generation immunotherapy, to individualise cancer treatment Can sales double in the next five years? based on the characteristics of each patient’s tumour. The Yes. Revenue uptick from the approved Co

2. Slide 2: Risk factors

   Risk factors The views expressed in this presentation are those of the author and should not be considered as advice or a recommendation to buy, sell or hold a particular investment. They reflect personal opinion and should not be taken as statements of fact nor should any reliance be placed on them

3. Slide 3: Important information

   Important information All investment strategies have the potential for profit and loss. its investment management and advisory services and distribute Baillie Gifford Worldwide Funds plc in The Netherlands.BGE also has a representative office in Zurich, Switzerland pursuant to Art. 58 of Stock Examp

4. Slide 4: Important information

   Important information Important Information South Africa Important Information Japan BGO is licensed with the Financial Sector Conduct Authority in South Africa as a Financial Services MUBGAM is a joint venture company between Mitsubishi UFJ Trust & Banking Corporation Provider (FSP No 44870) in ter

BioNTech — Investor Presentation (December 2023) on 6ix